Editorial policy
How Line & Light separates source-specific outcomes, current provider records, commercial terms and unanswered individual care questions.
Identify the exact preparation
We distinguish an approved product label from an ingredient-family discussion and from a compounded formula. A finding about RENOVA 0.02% remains attached to that preparation and its wider care context; it does not establish the effect or approval of another product.
Keep the limits in the reading
Fine facial lines, deeper wrinkles, photographic appearance and patient safety are different questions. We preserve the source population, formula, method and reported outcome when they matter. An attractive image, irritation or a seller’s adjustment narrative is not accepted as proof of efficacy.
Read the full commercial record
Reviews retain the period and total beside any monthly display. Consultation fees, conditional refunds, subscriptions and unresolved supplied quantities remain visible. An advertised purchase term does not become a personal treatment duration.
Make the commercial position explicit
CoreAge’s first position is disclosed because Line & Light is in its promotional publishing network. It does not represent a clinical ranking. Public-source articles have no claimed clinician sign-off, patient testing or independent purchase experience.
Make sources discoverable
Inline citations lead to article source entries and the complete register. Sources link back to related articles and fixed reading records. Dates describe source access, not proof that an offer will remain unchanged. Provider and clinical records can change after publication.